首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >The International Registry on Hand and Composite Tissue Transplantation.
【24h】

The International Registry on Hand and Composite Tissue Transplantation.

机译:国际手和复合组织移植登记处。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Since May 2002 all groups performing hand transplantations have supplied detailed information to the International Registry on Hand and Composite Tissue Transplantation. This inaugural report provides a review of all hand transplants performed to date. METHODS: Between September 1998 and September 2004, 18 male patients underwent 24 hand/forearm/digit transplantations (11 monolateral and 4 bilateral hand transplantations, 2 bilateral forearm transplantations, and 1 thumb transplantation). The level of amputation was mostly at the distal forearm or wrist. The average age of the patient was 32 years. Time since hand loss ranged from 2 months to 22 years. Immunosuppressive therapy included tacrolimus, mycophenolate mofetil, rapamycin, and steroids; polyclonal or monoclonal antibodies were used for induction. Topical immunosuppression was administered in some patients. Follow-up period ranged from 17 to 70 months. RESULTS: Patient survival was 100%. Graft survival was 100% at 1 and 2 years. Twocases of graft failure at a later date were caused by severe inflammation and progressive rejection in a noncompliant patient. Acute rejection episodes occurred in 12 patients within the first year. Rejection was reversible in all compliant patients. Side effects included opportunistic infections and metabolic complications. No life-threatening complications or malignancies were reported. All patients had achieved protective sensation, and 17 patients also achieved discriminative sensation. Extrinsic and intrinsic muscle recovery enabled patients to perform most daily activities. CONCLUSIONS: Despite the enormous antigen load associated with composite tissue allograft, hand transplantation became a clinical reality with immunosuppression comparable to transplantation of solid organs.
机译:背景:自2002年5月以来,所有进行手部移植的小组都向国际手部和复合组织移植登记处提供了详细的信息。这份就职报告总结了迄今为止进行的所有手部移植手术。方法:在1998年9月至2004年9月之间,对18例男性患者进行了24例手/前臂/指骨移植(11例单侧和4例双侧手移植,2例双侧前臂移植和1例拇指移植)。截肢水平主要在前臂或腕部远端。患者的平均年龄为32岁。自手失失后的时间从2个月到22年不等。免疫抑制疗法包括他克莫司,霉酚酸酯,雷帕霉素和类固醇。多克隆或单克隆抗体用于诱导。在某些患者中进行了局部免疫抑制。随访期为17至70个月。结果:患者生存率为100%。移植后1年和2年的存活率为100%。后来有两例移植失败的原因是严重的炎症和不依从患者的进行性排斥反应。第一年内有12例患者发生了急性排斥反应。在所有依从性患者中排斥反应都是可逆的。副作用包括机会感染和代谢并发症。没有报道危及生命的并发症或恶性肿瘤。所有患者均获得保护性感觉,并且17位患者也具有歧视性感觉。外在和内在的肌肉恢复使患者能够执行大多数日常活动。结论:尽管复合组织同种异体移植具有巨大的抗原负荷,但手移植已成为具有与实体器官移植相当的免疫抑制作用的临床现实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号